D&D Pharmatech (347850.KQ)

KRW 47200.0

(0.21%)

Inventory Summary of D&D Pharmatech

  • D&D Pharmatech's latest annual inventory in 2023 was 3.45 Billion KRW , down -55.81% from previous year.
  • D&D Pharmatech's latest quarterly inventory in 2024 Q2 was 5.73 Billion KRW , down 0.0% from previous quarter.
  • D&D Pharmatech reported annual inventory of 7.8 Billion KRW in 2022, up 36.47% from previous year.
  • D&D Pharmatech reported annual inventory of 5.72 Billion KRW in 2021, down -3.55% from previous year.
  • D&D Pharmatech reported quarterly inventory of 5.73 Billion KRW for 2024 Q2, down 0.0% from previous quarter.
  • D&D Pharmatech reported quarterly inventory of - KRW for 2023 Q1, down -100.0% from previous quarter.

Annual Inventory Chart of D&D Pharmatech (2023 - 2019)

Historical Annual Inventory of D&D Pharmatech (2023 - 2019)

Year Inventory Inventory Growth
2023 3.45 Billion KRW -55.81%
2022 7.8 Billion KRW 36.47%
2021 5.72 Billion KRW -3.55%
2020 5.93 Billion KRW 0.0%
2019 - KRW 0.0%

Peer Inventory Comparison of D&D Pharmatech

Name Inventory Inventory Difference
HLB Co., Ltd. 11.42 Billion KRW 69.792%
iNtRON Biotechnology, Inc. 1.01 Billion KRW -241.233%
BINEX Co., Ltd. 28.26 Billion KRW 87.792%
Bioneer Corporation 41.35 Billion KRW 91.657%
Anterogen.Co.,Ltd. 1.91 Billion KRW -80.592%
MEDIPOST Co., Ltd. 14.51 Billion KRW 76.233%
CrystalGenomics, Inc. 1.55 Billion USD -121.909%
Helixmith Co., Ltd 914.11 Million KRW -277.439%
Chabiotech Co.,Ltd. 34.11 Billion KRW 89.887%
Medy-Tox Inc. 59.61 Billion KRW 94.213%
Peptron, Inc. 172.18 Million KRW -1903.759%
Amicogen, Inc. 46.83 Billion KRW 92.634%
Genexine, Inc. 3.8 Billion KRW 9.37%
HLB Therapeutics Co.,Ltd. 5.33 Billion KRW 35.339%
LegoChem Biosciences, Inc. 196.83 Million KRW -1652.854%
ALTEOGEN Inc. 1.06 Billion KRW -222.946%
PharmaResearch Co., Ltd. 50.23 Billion KRW 93.131%
SillaJen, Inc. 1.21 Billion KRW -184.525%
JETEMA, Co., Ltd. 12.74 Billion KRW 72.92%
OliX Pharmaceuticals,Inc 468.4 Million KRW -636.582%
Genomictree Inc. 496.53 Million KRW -594.864%
MedPacto, Inc. 620.00 KRW -556486870.968%
EASY BIO,Inc. 25.93 Billion KRW 86.699%
GI Innovation, Inc. - KRW -Infinity%